# Clinical Utility of Selected Circulating Tumor DNA Assays in Patients With Advanced Malignancy

> **NCT06290856** · — · TERMINATED · sponsor: **Oslo University Hospital** · enrollment: 16 (actual)

## Conditions studied

- Metastatic Colorectal Cancer
- Pancreas Adenocarcinoma
- Cholangiocarcinoma

## Interventions

- **DIAGNOSTIC_TEST:** Multiplex PCR-test for circulating tumor DNA

## Key facts

- **NCT ID:** NCT06290856
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2024-01-15
- **Primary completion:** 2024-07-15
- **Final completion:** 2024-07-15
- **Target enrollment:** 16 (ACTUAL)
- **Why stopped:** The platform used for detecting ctDNA was not sensitive enough.
- **Last updated:** 2026-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06290856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06290856, "Clinical Utility of Selected Circulating Tumor DNA Assays in Patients With Advanced Malignancy". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06290856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*